Literature DB >> 8505645

The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.

R Whurr1, M Lorch, H Fontana, G Brookes, A Lees, C D Marsden.   

Abstract

Botulinum toxin injections have been used to treat 31 patients with adductor spasmodic dysphonia. Injections of 3.00-3.75 units of botulinum toxin were performed bilaterally into the thyroarytenoid muscle. This treatment significantly decreased the standard deviation of the fundamental frequency of the speech sample, indicating a reduction in the variability of pitch amongst patients. A total of 96% of patients' subjective diary reports showed an improvement with a median of 7 days to peak effect and a 5 week duration of peak effect.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8505645      PMCID： PMC1015013          DOI： 10.1136/jnnp.56.5.526

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  16 in total

Review 1.  [EXPERIMENTAL RESEARCH ON SPASTIC DYSPHONIA].

Authors:  J KIML
Journal:  Folia Phoniatr (Basel)       Date:  1965

2.  Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia).

Authors:  A Blitzer; M F Brin; S Fahn; R E Lovelace
Journal:  Laryngoscope       Date:  1988-02       Impact factor: 3.325

3.  Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias.

Authors:  A Blitzer; M F Brin; S Fahn; D Lange; R E Lovelace
Journal:  Laryngoscope       Date:  1986-11       Impact factor: 3.325

4.  Focal cranial dystonia.

Authors:  L A Golper; J G Nutt; M T Rau; R O Coleman
Journal:  J Speech Hear Disord       Date:  1983-05

5.  Electromyographic findings in focal laryngeal dystonia (spastic dysphonia).

Authors:  A Blitzer; R E Lovelace; M F Brin; S Fahn; M E Fink
Journal:  Ann Otol Rhinol Laryngol       Date:  1985 Nov-Dec       Impact factor: 1.547

6.  Experiences with recurrent laryngeal nerve section for spastic dysphonia.

Authors:  B Fritzell; E Feuer; S Haglund; E Knutsson; H Schiratzki
Journal:  Folia Phoniatr (Basel)       Date:  1982

7.  Spastic dysphonia and Meigs disease.

Authors:  D E Jacome; G F Yanez
Journal:  Neurology       Date:  1980-04       Impact factor: 9.910

8.  Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases.

Authors:  A Blitzer; M F Brin; S Fahn; R E Lovelace
Journal:  Laryngoscope       Date:  1988-06       Impact factor: 3.325

9.  Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection.

Authors:  A E Aronson; L W De Santo
Journal:  Laryngoscope       Date:  1983-01       Impact factor: 3.325

10.  Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.

Authors:  R H Miller; G E Woodson; J Jankovic
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-06
View more
  5 in total

Review 1.  Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology.

Authors:  A Berardelli; G Abbruzzese; L Bertolasi; G Cantarella; F Carella; A Currà; D De Grandis; G DeFazio; G Galardi; P Girlanda; P Livrea; N Modugno; A Priori; G Ruoppolo; L Vacca; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1997-10

2.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

Authors:  G L Sheean; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

Review 3.  Evidence for the effectiveness of botulinum toxin for spasmodic dysphonia from high-quality research designs.

Authors:  C R Watts; D D Truong; C Nye
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

Review 4.  Botulinum toxin injections for the treatment of spasmodic dysphonia.

Authors:  C C W Watts; R Whurr; C Nye
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 5.  Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.

Authors:  Michael P Cannito; Joel C Kahane; Lesya Chorna
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.